Carl Zeiss Meditec (ETR:AFX) Trading Down 2.2% – Here’s Why

Carl Zeiss Meditec AG (ETR:AFXGet Free Report)’s stock price dropped 2.2% on Thursday . The stock traded as low as €64.50 ($70.88) and last traded at €65.75 ($72.25). Approximately 129,192 shares were traded during mid-day trading, an increase of 37% from the average daily volume of 94,405 shares. The stock had previously closed at €67.25 ($73.90).

Carl Zeiss Meditec Stock Down 2.2 %

The company has a current ratio of 3.51, a quick ratio of 2.47 and a debt-to-equity ratio of 6.74. The business’s 50-day simple moving average is €62.66 and its 200-day simple moving average is €78.14. The company has a market capitalization of $5.88 billion, a PE ratio of 28.84, a price-to-earnings-growth ratio of 2.83 and a beta of 0.98.

About Carl Zeiss Meditec

(Get Free Report)

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.

See Also

Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.